This alliance is aimed at providing trials that boost patient access, engagement and retention, thereby improving the effectiveness of the research.
The varied workforce of CVS Health can aid in enhancing the care delivery and clinical trial services that are culturally inclusive, Medable stated.
CVS Health Clinical Trial Services (CTS) has been designing and offering novel methods to research and real-world data generation by collaborating with crucial stakeholders in the biopharmaceutical sector and across the trial ecosystem since May last year.
As part of the latest partnership, CVS Health will provide precision patient recruitment using innovative analytics, national reach, and local community connections.
Furthermore, CVS Health will provide decentralised options for the delivery of Phase III/IV trials, as well as real-world evidence studies at the select MinuteClinic locations, in-home using its Coram home health services team, and virtually.
Medable chief growth officer Sans Thakur said: “This collaboration intends to bridge research and science into communities with local access and experience that builds greater trust in health and medicine.
“Practical applications of Medable technology with the reach and experience of CVS Health gives us an opportunity to harness this time of change and respond differently to unmet needs in local communities.”
In December last year, Medable partnered with Vault Health to combine the former’s end-to-end software platform with the latter’s expertise in diagnostics, logistics and remote care services for decentralised trials.